IT
ITGR.US Integer Holdings Corp
- Market cap
- USD 4.31B
- P/E
- 42.5x
- P/B
- 2.50x
- ROE
- 4.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is ITGR.US undervalued?
Graham numberITGR.US trades 117.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Integer Holdings Corp fundamental analysis
No fundamental analysis for Integer Holdings Corp yet.
Integer Holdings Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Integer Holdings Corp
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides car…
Full company profileInteger Holdings Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Integer Holdings Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.08B | 1.14B | 1.22B | 1.26B | 1.07B | 1.22B | 1.33B | 1.56B | 1.72B | 1.85B | 1.80B |
| Gross Profit | 338M | 354M | 363M | 355M | 286M | 337M | 347M | 412M | 461M | 426M | 432M |
| Operating Income | 92.9M | 126M | 156M | 158M | 121M | 136M | 113M | 163M | 208M | 209M | 131M |
| EBITDA | 246M | 266M | 261M | 247M | 183M | 224M | 223M | 278M | 334M | 298M | 259M |
| Net Income | 5.96M | 66.7M | 168M | 96.3M | 77.3M | 96.8M | 66.4M | 90.7M | 120M | 103M | 73.5M |
| EPS | 0.19 | 2.08 | 5.15 | 2.92 | 2.33 | 2.91 | 1.99 | 2.69 | 3.36 | 2.89 | 2.12 |
| Balance Sheet | |||||||||||
| Total Assets | 2.83B | 2.85B | 2.33B | 2.35B | 2.37B | 2.58B | 2.79B | 2.94B | 3.08B | 3.41B | 3.39B |
| Total Liabilities | 2.11B | 1.95B | 1.27B | 1.20B | 1.10B | 1.23B | 1.38B | 1.42B | 1.46B | 1.66B | 1.67B |
| Shareholders' Equity | 725M | 893M | 1.06B | 1.15B | 1.27B | 1.35B | 1.42B | 1.52B | 1.62B | 1.75B | 1.73B |
| Cash & Short-term Investments | 52.1M | 44.1M | 25.6M | 13.5M | 49.2M | 17.9M | 24.3M | 23.7M | 46.5M | 17.2M | 14.1M |
| Total Debt | 1.73B | 1.61B | 926M | 859M | 778M | 906M | 1.01B | 1.05B | 1.10B | 1.40B | 1.34B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 106M | 149M | 167M | 165M | 181M | 157M | 116M | 180M | 205M | 196M | 161M |
| Capital Expenditure | 58.6M | 47.3M | 44.9M | 48.2M | 51.4M | 53.5M | 74.7M | 120M | 105M | 91.0M | 89.6M |
| Free Cash Flow | 46.9M | 102M | 122M | 117M | 130M | 103M | 41.7M | 60.3M | 99.8M | 105M | 71.8M |
| Ratios | |||||||||||
| ROE | 0.8% | 7.5% | 15.8% | 8.4% | 6.1% | 7.1% | 4.7% | 6.0% | 7.4% | 5.9% | 4.3% |
| ROA | 0.2% | 2.3% | 7.2% | 4.1% | 3.3% | 3.7% | 2.4% | 3.1% | 3.9% | 3.0% | 2.2% |
| Net Profit Margin | 0.6% | 5.9% | 13.8% | 7.7% | 7.2% | 7.9% | 5.0% | 5.8% | 7.0% | 5.6% | 4.1% |
| Debt to Equity | 2.39x | 1.80x | 0.87x | 0.75x | 0.61x | 0.67x | 0.71x | 0.69x | 0.68x | 0.80x | 0.78x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Integer Holdings Corp dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 2.93M | 0.09 | 4.4% |
| 2021 | USD 3.85M | 0.12 | 4.0% |
| 2020 | USD 557K | 0.02 | 0.7% |
| 2019 | USD 41.0K | 0.00 | 0.0% |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Integer Holdings Corp
- Insiders 3.42%
- Institutions 96.59%
- Public & others 0.00%
- Shares outstanding 34.0M
- Free float 28.9M
Top funds holding ITGR.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 2.05M | 6.02% | +0.05% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.08M | 3.18% | -0.28% | Sep 2026 |
| iShares Russell 2000 ETF | 870K | 2.56% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 765K | 2.25% | -1.93% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 498K | 1.46% | +0.38% | Sep 2026 |
| DFA U.S. Small Cap Value I | 397K | 1.17% | +11.27% | Sep 2026 |
| Fidelity Small Cap Index | 375K | 1.10% | +0.21% | Aug 2026 |
| iShares Russell 2000 Value ETF | 322K | 0.95% | 0.00% | Oct 2026 |
| State Street SPDR Port S&P 600 Sm CpETF | 310K | 0.91% | -0.05% | Oct 2026 |
| Brown Advisory Small-Cap Fdmtl Val Inv | 284K | 0.83% | -1.26% | Sep 2026 |
| iShares S&P Small-Cap 600 Value ETF | 282K | 0.83% | 0.00% | Oct 2026 |
| Vanguard Tax-Managed Small Cap Adm | 208K | 0.61% | -11.38% | Sep 2026 |
| Harbor Small Cap Value Instl | 207K | 0.61% | -43.94% | Sep 2026 |
| Vanguard Russell 2000 ETF | 199K | 0.59% | +1.14% | Sep 2026 |
| FullerThaler Behavioral Sm-Cp Eq R6 | 191K | 0.56% | +4.26% | Jun 2026 |
| State Street® SPDR® S&P 600™ Sm CpValETF | 184K | 0.54% | 0.00% | Oct 2026 |
| Schwab US Small-Cap ETF™ | 180K | 0.53% | +0.23% | Oct 2026 |
| Heartland Value Investor | 172K | 0.50% | 0.00% | Oct 2026 |
| iShares US Medical Devices ETF | 162K | 0.48% | -1.12% | Oct 2026 |
| Fidelity Extended Market Index | 157K | 0.46% | -6.26% | Sep 2026 |
Top institutions holding ITGR.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 5.35M | 15.75% | +0.90% | Jun 2026 |
| Amvescap Plc. | 2.25M | 6.61% | +14.11% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 2.04M | 6.00% | -0.32% | Jun 2026 |
| Nomura Holdings Inc | 1.55M | 4.57% | +246.70% | Jun 2026 |
| Vanguard Capital Management, LLC | 1.53M | 4.51% | -0.35% | Jun 2026 |
| State Street Corp | 1.41M | 4.16% | +1.06% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 1.35M | 3.96% | -12.57% | Jun 2026 |
| Irenic Capital Management LP | 1.26M | 3.72% | +0.05% | Jun 2026 |
| Hudson Bay Capital Management LP | 1.00M | 2.94% | 0.00% | Jun 2026 |
| Citadel Advisors Llc | 966K | 2.84% | +39.35% | Jun 2026 |
| AllianceBernstein L.P. | 913K | 2.69% | -29.94% | Jun 2026 |
| Geode Capital Management, LLC | 879K | 2.59% | +5.40% | Jun 2026 |
| Massachusetts Financial Services Company | 788K | 2.32% | -2.19% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 779K | 2.29% | -52.15% | Sep 2026 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 779K | 2.29% | -4.93% | Jun 2026 |
| SG Americas Securities, LLC | 646K | 1.90% | +65.20% | Jun 2026 |
| The Goldman Sachs Group Inc | 577K | 1.70% | +66.91% | Jun 2026 |
| Manufacturers Life Insurance Co | 545K | 1.60% | -8.95% | Jun 2026 |
| Brown Advisory Holdings Inc | 544K | 1.60% | 0.00% | Jun 2026 |
| Earnest Partners LLC | 513K | 1.51% | -49.11% | Sep 2026 |
Integer Holdings Corp company profile
- Company name
- Integer Holdings Corp
- Ticker
- ITGR.US
- Exchange
- USA Stocks
- Listed since
- Sep 29, 2000
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 11,000
- Fiscal year end
- December
- Address
- 5830 Granite Parkway, Plano, TX, United States, 75024
- Phone
- 214 618 5243
- Website
- integer.net
About Integer Holdings Corp
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Integer Holdings Corp management
10- Mr. Payman KhalesCEO, President & Director · born 1970
- Mr. Diron SmithExecutive VP & CFO · born 1973
- Ms. Lindsay Krause Blackwood J.D.Senior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary · born 1977
- Mr. Andrew SennPresident of Growth & Innovation · born 1982
- Mr. Jim StephensExecutive Vice President of Special Projects · born 1974
- Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting Officer · born 1971
- Ms. Carol RussellVP & Chief Information Officer
- Ms. Kristen Marie Stewart C.F.A.Director of Investor Relations
- Mr. Kirk K. Thor Ph.D.Executive VP & Chief Human Resources Officer · born 1964
- Mr. John HarrisPresident of Global Operations & Manufacturing Technology · born 1960